What is Revvity's free cash flow?

Latest reported free cash flow for Revvity (RVTY) is $493.92M as of the trailing twelve months (TTM) ending April 5, 2026.

How has Revvity free cash flow changed year-over-year?

Revvity (RVTY) free cash flow changed -6.2% year-over-year on the latest annual filing.

What is the long-term growth rate of Revvity free cash flow?

Revvity (RVTY) free cash flow compound annual growth rate is -9.3% over the most recent 5 years available.

When did Revvity free cash flow hit its highest annual value?

Revvity free cash flow reached its highest annual value of $1.32B in 2021.

What was Revvity free cash flow in 2024?

Revvity (RVTY) free cash flow in 2024 was $541.65M.

What was Revvity free cash flow in 2025?

Revvity (RVTY) free cash flow in 2025 was $508.25M.

Revvity (RVTY) Free Cash Flow

Latest period

$493.92M

YoY change

-6.2%

5Y CAGR

-9.3%

Peak year (2021)

$1.32B

Free Cash Flow history chart for Revvity (RVTY) from 1989 to 2025

Latest: $508.25M

Free Cash Flow growth chart for Revvity (RVTY) from 1989 to 2025

Latest: -6.2%

Free Cash Flow history table for Revvity (RVTY) from 1989 to 2025


2025	$508.25M	-6.2%	−$33.40M	Dec 28, 2025	Feb 24, 2026
2024	$541.65M	+5369.0%	+$531.75M	Dec 29, 2024	Feb 25, 2025
2023	$9.90M	-98.3%	−$584.27M	Dec 31, 2023	Dec 31, 2023
2022	$594.18M	-55.1%	−$730.55M	Dec 31, 2022	Dec 31, 2022
2021	$1.32B	+59.9%	+$496.19M	Dec 31, 2021	Dec 31, 2021
2020	$828.54M	+193.7%	+$546.40M	Dec 31, 2020	Dec 31, 2020
2019	$282.14M	+29.5%	+$64.35M	Dec 31, 2019	Dec 31, 2019
2018	$217.78M	-12.7%	−$31.58M	Dec 31, 2018	Dec 31, 2018
2017	$249.36M	-21.8%	−$69.55M	Dec 31, 2017	Dec 31, 2017
2016	$318.91M	+23.9%	+$61.45M	Dec 31, 2016	Dec 31, 2016
2015	$257.47M	+2.0%	+$4.94M	Dec 31, 2015	Dec 31, 2015
2014	$252.53M	+111.1%	+$132.93M	Dec 31, 2014	Dec 31, 2014
2013	$119.60M	+9.0%	+$9.84M	Dec 31, 2013	Dec 31, 2013
2012	$109.76M	-43.5%	−$84.52M	Dec 31, 2012	Dec 31, 2012
2011	$194.28M	+48.8%	+$63.67M	Dec 31, 2011	Dec 31, 2011
2010	$130.61M	+11.6%	+$13.57M	Dec 31, 2010	Dec 31, 2010
2009	$117.04M	-32.9%	−$57.48M	Dec 31, 2009	Dec 31, 2009
2008	$174.52M	+10.4%	+$16.37M	Dec 31, 2008	Dec 31, 2008
2007	$158.15M	+90.6%	+$75.18M	Dec 31, 2007	Dec 31, 2007
2006	$82.97M	-54.7%	−$100.08M	Dec 31, 2006	Dec 31, 2006
2005	$183.04M	+0.7%	+$1.25M	Dec 31, 2005	Dec 31, 2005
2004	$181.80M	+21.3%	+$31.87M	Dec 31, 2004	Dec 31, 2004
2003	$149.93M	+345.1%	+$116.24M	Dec 31, 2003	Dec 31, 2003
2002	$33.69M	-2.6%	−$915.00K	Dec 31, 2002	Dec 31, 2002
2001	$34.60M	-53.8%	−$40.35M	Dec 31, 2001	Dec 31, 2001
2000	$74.95M	-132.9%	+$302.55M	Dec 31, 2000	Dec 31, 2000
1999	−$227.60M	+16.8%	−$32.70M	Dec 31, 1999	Dec 31, 1999
1998	−$194.90M	+1302.2%	−$181.00M	Dec 31, 1998	Dec 31, 1998
1997	−$13.90M	+4533.3%	−$13.60M	Dec 31, 1997	Dec 31, 1997
1996	−$300.00K	-100.3%	−$88.70M	Dec 31, 1996	Dec 31, 1996
1995	$88.40M	+50.9%	+$29.80M	Dec 31, 1995	Dec 31, 1995
1994	$58.60M	-30.4%	−$25.60M	Dec 31, 1994	Dec 31, 1994
1993	$84.20M	-20.1%	−$21.20M	Dec 31, 1993	Dec 31, 1993
1992	$105.40M	+35.5%	+$27.60M	Dec 31, 1992	Dec 31, 1992
1991	$77.80M	-28.9%	−$31.60M	Dec 31, 1991	Dec 31, 1991
1990	$109.40M	+275.9%	+$80.30M	Dec 31, 1990	Dec 31, 1990
1989	$29.10M	—	—	Dec 31, 1989	Dec 31, 1989

2025$508.25M-6.2%
2024$541.65M+5369.0%
2023$9.90M-98.3%
2022$594.18M-55.1%
2021$1.32B+59.9%
2020$828.54M+193.7%
2019$282.14M+29.5%
2018$217.78M-12.7%
2017$249.36M-21.8%
2016$318.91M+23.9%
2015$257.47M+2.0%
2014$252.53M+111.1%
2013$119.60M+9.0%
2012$109.76M-43.5%
2011$194.28M+48.8%
2010$130.61M+11.6%
2009$117.04M-32.9%
2008$174.52M+10.4%
2007$158.15M+90.6%
2006$82.97M-54.7%
2005$183.04M+0.7%
2004$181.80M+21.3%
2003$149.93M+345.1%
2002$33.69M-2.6%
2001$34.60M-53.8%
2000$74.95M-132.9%
1999−$227.60M+16.8%
1998−$194.90M+1302.2%
1997−$13.90M+4533.3%
1996−$300.00K-100.3%
1995$88.40M+50.9%
1994$58.60M-30.4%
1993$84.20M-20.1%
1992$105.40M+35.5%
1991$77.80M-28.9%
1990$109.40M+275.9%
1989$29.10M—

Free Cash Flow values are taken from Revvity's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Free Cash Flow at Revvity (RVTY)

Free Cash Flow for Revvity (RVTY): headline value $493.92M · YoY -6.2%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending April 5, 2026 (reported May 12, 2026). Chart and table below cover the full reported history back to 1989.

In 2025, Revvity (RVTY) free cash flow totalled $508.25M – declined 6.2% year-over-year.

Over 2020–2025 (5 years), Revvity free cash flow expanded at a -9.3% compound annual rate, with a net decline across the window.

Revvity free cash flow plunged from $1.32B in 2021 to $508.25M in 2025, a 61.6% drawdown.

2021 marks the peak free cash flow at $1.32B, with the historical low of −$227.60M recorded in 1999.

Revvity Free Cash Flow by Year

Revvity Free Cash Flow 2025: $508.25M

2025's free cash flow for Revvity came in at $508.25M, declined 6.2% below 2024.

Revvity Free Cash Flow 2024: $541.65M

Revvity posted free cash flow of $541.65M in 2024, surged 5369.0% from 2023.

Revvity Free Cash Flow 2023: $9.90M

In 2023, Revvity reported free cash flow of $9.90M, plunged 98.3% below 2022.

Revvity Free Cash Flow 2022: $594.18M

Revvity free cash flow in 2022 was $594.18M, plunged 55.1% below 2021.

Revvity Free Cash Flow 2021: $1.32B

Revvity free cash flow in 2021 was $1.32B.

See more financial history for Revvity (RVTY).

Sector peers by Free Cash Flow

Healthcare peers of Revvity (RVTY), ranked by their latest free cash flow


Johnson & Johnson (JNJ)	$19.70B
AbbVie (ABBV)	$17.82B
UnitedHealth Group (UNH)	$16.07B
Merck & Co. (MRK)	$12.36B
Eli Lilly (LLY)	$8.97B
AstraZeneca (AZN)	$8.67B
Amgen (AMGN)	$8.10B
Novo Nordisk (NVO)	$4.52B

Frequently asked questions

Revvity (RVTY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation